Skip to main content
. Author manuscript; available in PMC: 2019 Mar 26.
Published in final edited form as: Dig Dis Sci. 2018 Mar 28;63(6):1525–1531. doi: 10.1007/s10620-018-5030-7

Table 1.

Antimicrobial exposure among residents colonized and not colonized with Clostridium difficile

Antimicrobial group N (%) Controls (C.
difficile−)
N = 21
Cases (C.
difficile +)
N = 7
P value

Penicillins 1 (5) 0 1.00
Extended spectrum penicillins 3 (14) 0 0.55
First-generation cephalosporins 3 (14) 1 (14) 1.00
Other cephalosporins 4 (19) 3 (43) 0.32
Carbapenems 1 (5) 1 (14) 0.44
Quinolones 7 (33) 0 0.14
Azithromycin 1 (5) 0 1.00
Doxycycline 0 0
Trimethoprim-sulfameth-oxazole 2 (10) 3 (43) 0.08
Nitrofurantoin 4 (19) 1 (14) 1.00
Gentamicin 0 0
Vancomycin 2 (10) 0 1.00
Linezolid 0 0